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Inappropriate antibiotic prescribing increases the prevalence of antibiotic resistance. While 
evidence-based practice guidelines can reduce antibiotic use, inconsistent adherence to these 
guidelines results in ineffective treatment, increased cost, and increasing antibiotic resistance. 
Context 
At Athena Med-Monterey, a multi-provider primary care clinic where approximately 90% of the 
patients are women, written guidelines for uncomplicated urinary tract infections (uUTIs) in 
premenopausal non-pregnant women (PrMNPW) are lacking. In addition, there are no processes 
for assessing adherence to clinical guidelines. 
Interventions 
The advanced practice nurse (APN) led a quality improvement process to assess and promote 
adherence to practice guidelines using a small test of change and the plan-do-study-act (PDSA) 





This project examined the clinicians’ adherence to evidenced-based guidelines and use of first-
line agents to treat uUTIs in PrMNPW, and evaluated opportunities for ongoing practice 
improvement in treating uUTIs and adherence to clinical practice guidelines. 
Results 
The quality improvement process successfully evaluated and promoted adherence to evidence-
based practice guidelines. Both the qualitative assessment and retrospective chart reviews found 
that the clinicians used evidence-based guidelines and first-line agents to treat uUTIs in 
PrMNPW. No practice improvement intervention was needed for antibiotic treatment of this 
specific condition. 
Conclusions 
The clinicians’ adherence to the guidelines yielded desired practice and patient outcomes. The 
APN-driven small test of change and PDSA method demonstrated success in implementing a 
process to evaluate and promote evidence-based guidelines and first-line agents to treat 
infections in primary care.  
 Keywords: small test of change, plan-do-study-act, uncomplicated urinary tract 






Promoting Antibiotic Stewardship in Primary Care Setting: An Evaluation Process of 
Treatment Practices for Uncomplicated Urinary Tract Infections in Premenopausal Non-
Pregnant Women 
Background 
Antibiotic resistance leads to approximately 2.8 million infections and 35,000 deaths per 
year in the United States. Growth of pathogens resistant to first-line agents can require 
management with expensive and toxic alternative agents, leading to increased antibiotic-resistant 
conditions and death rate. Inappropriate antibiotic prescribing in primary health care setting is 
the foremost modifiable risk factor for antibiotic resistance (CDC, 2021). While, antibiotic 
stewardship requires adherence to evidence-based recommendations for diagnosis and 
management, outpatient stewardship efforts could improve antibiotic prescribing practices and 
clinical outcomes (Sanchez, et al., 2016). 
Problem Description 
Urinary tract infections (UTIs) are the most common outpatient infection in primary 
healthcare, generating an overall annual cost of $1.6 billion in the United States (Medina & 
Castillo-Pino, 2019). UTIs are prevalent in women 14–24 years old, and more than half of all 
adult women will have at least one UTI in their lifetime. The unnecessary use of antibiotics for 
treating such infections contributes to the increasing national and global prevalence of antibiotic 
resistance (Llor & Bjerrum, 2014). While practice guidelines and other research studies have 
aimed to reduce antibiotic use, few primary care providers (PCPs) rely directly on these 
guidelines to treat uncomplicated UTIs (Grigoryan et al., 2019).  
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In 2011, the International Clinical Practice Guidelines for the Treatment of Acute 
Uncomplicated Cystitis (AUC) and Pyelonephritis in Pre-Menopausal Non-Pregnant Women 
(PrMNPW) were published by the Infectious Diseases Society of America (IDSA) and the 
European Society for Microbiology and Infectious Diseases (Gupta et al., 2011). These 
guidelines were released to decrease the occurrence of treatment-resistant uropathogens. 
According to the guideline, women who have dysuria with no complicating features can be 
treated for cystitis without any further diagnostic evaluation (Michels & Sands, 2015). Regarding 
acute pyelonephritis, the 2011 IDSA guidelines emphasized treatment with oral ciprofloxacin, 
levofloxacin, or sulfamethoxazole-trimethoprim (SMX-TMP) appropriately tailored to the 
patient’s urine culture and susceptibility test results.  
Setting 
 Athena Med-Monterey (Athena Healthcare Systems, 2020) is a multi-practice 
clinic with multiple providers who are experts in their fields ( including obstetrics and 
gynecology, internal medicine, occupational medicine, and advanced practice nursing). 
About 90% of patients seen in the clinic are women. Women who present with UTI 
symptoms are prescribed antibiotics, either at the initial visit or after two days, when the 
urine culture and sensitivity results are available. If available, the clinicians refer to the urine 
culture results to confirm the antibiotic chosen for UTI treatment. To meet and quantify the 
organization’s goal of efficient and timely treatment, the clinic could use quality 
measurement tools or evaluation processes to measure practices and outcomes. This action plan 
would ensure use of practice guidelines for consistency of care and provide decisive 
recommendations that would reassure clinicians of the appropriateness of the planned treatment 




 The overarching goal of this project was to improve patient outcomes by promoting 
practice improvement in primary healthcare, specifically adherence to evidenced-based clinical 
practice guidelines in antibiotic prescribing. The project evaluated the opportunities for practice 
improvement in the treatment of uUTI. The process of small test of change and PDSA method 
was developed for continuous evaluation and promotion of adherence to clinical practice 
guidelines. This project examined Athena Med-Monterey’s multi-provider primary clinic’s 
adherence to following evidenced-based guidelines, such as the 2011 IDSA guidelines, to treat 
PrMNPW presenting with symptoms of uUTI.  
 The overall goal of the proposed project was to design and implement a process for 
evaluating and supporting adherence to evidenced-based clinical practice guidelines. This project 
focused on using this process to promote prescription of first-line agents for treating uUTIs (as 
determined by clinical practice guidelines), a process that could be used in the future to evaluate 
adherence to other antibiotic prescribing guidelines. The 2011 IDSA guidelines are an 
evidenced-based tool that clinicians in primary healthcare should reference when treating uUTIs. 
The following objectives were used in the development of a process for evaluating and 
promoting adherence to clinical practice guidelines: 
1. Perform a provider-led small test of change using the PDSA method and the 2011 IDSA 
guidelines to establish clinical guidelines for treating uUTIs in PrMNPW. 
2. Evaluate clinicians’ adherence to use of evidence-based guidelines and first-line agents 
for treating uUTIs in PrMNPW, utilizing the small test of change and PDSA processes. 




4. If applicable, integrate the 2011 IDSA guidelines into the clinic’s current clinical 
practices for treating uUTIs in PrMNPW. 
5. Provide evaluation feedback to the clinic leadership. 
Available Knowledge 
PICOT Question 
 The PICOT question that guided this project is: Does primary healthcare clinicians’ (P) 
adherence to utilization of evidenced-based clinical practice guidelines (I) improve patient 
outcomes (O), compared with treatment without the use of clinical practice guidelines (C), over 4 
weeks of small test of change (T)? State authorized prescribing clinicians in primary healthcare 
is the population of interest in this project.  The use and availability of evidence-based clinical 
practice guidelines (vs. no use of clinical practice guidelines) increase adherence to prescribing 
first-line agents for treating uUTIs in PrMNPW and yield desired outcomes in terms of symptom 
resolution and cost-effectiveness. This literature reviewed for this project sought to evaluate 
whether provider adherence to evidenced-based clinical guidelines has improved since the 2017 
Centers for Disease Control and Prevention (CDC) guidelines for treating uUTIs were released 
(Table 1). The literature review also examined whether integrating the 2011 IDSA guidelines 
into multi-provider primary care organizations increases adherence to the prescription of first-
line agents and thereby improves the quality of clinical decisions and patient outcomes. 
Search Strategy 
 The literature review was conducted in compliance with the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA), and a systematic search for articles was 
conducted in the PubMed and Cochrane search engines using Boolean operators (AND, OR). 
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The inclusion criteria were articles that were published between 2017 and 2020, had text in 
English, and were peer-reviewed. The search terms “first-line antibiotics AND acute 
uncomplicated cystitis OR uncomplicated urinary tract infection” AND “prescription adherence 
AND first-line antibiotics AND acute uncomplicated cystitis OR uncomplicated urinary tract 
infection” were used initially. The search terms were then modified to “outcomes AND first-line 
antibiotics AND acute uncomplicated cystitis OR uncomplicated urinary tract infection.” The 
search resulted in 15 publications from 2017–2020 from both the PubMed and Cochrane 
databases. Additional search terms were “nitrofurantoin AND cystitis,” “fosfomycin AND 
cystitis,” and “sulfamethoxazole-trimethoprim AND cystitis.” Of the 15 publications, five aimed 
to evaluate prescriber adherence to the guidelines for treating uUTIs (Diagram 1). 
Integrated Review of the Literature 
 Robinson et al. (2019) evaluated the appropriateness of empiric fluoroquinolone (FQ) use 
compared to nitrofurantoin (NTF) use for treating AUC and determined the trends and predictors 
for using FQ. Women aged 19–64 who were given NTF, ciprofloxacin, or levofloxacin for AUC 
at five family medicine clinics were included in the study. Data regarding symptoms, 
comorbidities, allergies, creatinine clearance, recent antibiotic use, and urine cultures were used 
to determine whether empiric antibiotic treatment was appropriate based on national guidelines 
and local susceptibility data. Of the 567 women included in the study, 395 were given NTF, and 
172 were given FQ. Of these, 343 (86.8%) and 18 (10.5%) were appropriately prescribed NTF 
and FQ, respectively. Of the women inappropriately prescribed FQ, 15 (87.8%) lacked 
contraindication to NTF. Therefore, the study suggested the need for additional intervention and 
education to improve and decrease the use of FQ.  
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Yu et al. (2020) aimed to track and report outpatient antibiotic prescriptions in Medicare 
Part B older adult enrollees who were diagnosed with cystitis in an outpatient setting between 
2016 and 2017 in New York State (NYS). The inclusion criteria included an oral antibiotic 
prescription given less than three days after diagnosis of cystitis in Part D claims. According to 
the retrospective cohort study, 50,658 prescriptions were written upon discharge diagnosis of 
cystitis in NYS from 2016–2017. First-line antibiotic prescriptions of NTF, SMX-TMP, and 
fosfomycin (FM), as well as β-lactamase, increased, while FQ use decreased in both older female 
and male adults. The study suggested that the widespread prevalence of FQ and β-lactamase 
prescriptions requires outpatient antimicrobial stewardship.  
Giancola et al. (2019) conducted a quasi-experimental study that included women aged 
18–64 who were prescribed NTF, SMX-TMP, or ciprofloxacin within seven days of encounter at 
five family medicine clinics. Adherence to duration of treatment (DOT) based on the 2011 IDSA 
guidelines was evaluated. A stewardship intervention included revising/adding default 
prescription instructions to targeted antimicrobials in an EHR and performing a one-day in-
service at two (intervention group) of the five clinics. A total of 787 pre-intervention patients 
were compared to 862 post-intervention patients. After the intervention, the adherence rate to the 
recommended DOT increased from 31–89% for NTF and from 22–60% for SMX-TMP. 
Additionally, adherence to the recommended DOT increased in clinics that received education 
(33.7% vs. 90.2%; p < 0.01); these clinics’ adherence increased from 22.1–58.8% (p < 0.01). 
Revising/adding default prescription instructions and DOT to targeted antimicrobials in an EHR 




Pedela et al. (2017) evaluated changes in outpatient FQ and NTF use and resistance 
among E. coli isolates after a change in institutional guidelines that stipulated the use of NTF 
instead of FQ to treat AUC. The study compared the period from January 2003 to June 2007, 
when FQ was recommended as a first-line therapy for acute uUTIs, with the period from July 
2007 to December 2012, when NTF was recommended as the first-line therapy. The 
retrospective time series study included 5,714 adults treated for AUC and 11,367 outpatient E. 
coli isolates. After the change in institutional guidelines, FQ use showed an immediate 26% 
reduction, and FQ-resistant E. coli were stabilized. The use of NTF increased without changing 
NTF resistance.  
To identify the sources of information that guide antibiotic prescription decisions, 
Grigoryan et al. (2019) sought to understand why PCPs choose certain antibiotics or DOT. The 
study conducted a semi-structured interview with 18 PCPs in two family medicine clinics in 
Texas. Most PCPs reported that they prescribed SMX-TMP or NTF, but sometimes for a longer 
duration than recommended by the IDSA (2011). The PCPs also described multiple 
considerations when prescribing antibiotics, including allergies, sex, pregnancy, older age, past 
antibiotic experience and susceptibilities, familiarity with the antibiotic, shorter treatment 
duration and better compliance, UTI frequency, diabetes, and cost. Many PCPs mentioned that 
NTF was not as “strong” or as “quick” as SMX-TMP, and most were unfamiliar with FM. Few 
PCPs relied directly on guidelines to treat uUTIs; only two recalled and mentioned the 2011 
IDSA guidelines. Additionally, the PCPs had widely differing opinions on the extent to which 
antibiotic resistance was a problem in their practice. 
Summary of Evidence 
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 Evidence-based, multidisciplinary clinical guidelines are clear, reproducible, and flexible, 
and they assist clinicians in making decisions about appropriate healthcare for specific clinical 
circumstances (Field & Lohr, 1990). Trials, systematic reviews, and meta-analyses conducted 
after the CDC’s 2017 review of the 2011 IDSA guidelines (Table 2) found that clinicians who 
referenced these guidelines to manage uUTIs were most likely to achieve positive outcomes. The 
use and availability of evidence-based clinical practice guidelines (vs. no use of clinical practice 
guidelines) increased adherence to prescribing first-line agents for treating uUTIs in PrMNPW 
and yielded desired outcomes in terms of bacterial resolution and cost-effectiveness. The 
research in this literature review supports the potential efficacy of the 2011 IDSA guidelines into 
Athena Med-Monterey’s current uUTI management practices to potentially increase adherence to 
prescribing first-line agents for treating uUTIs in PrMNPW and improve the quality of clinical 
decisions and patient outcomes. The literature also supports the usefulness of implementing a 
process to evaluate and support clinicians’ adherence to antibiotic prescribing clinical practice 
guidelines for other infectious conditions in primary care. 
Rationale 
Theoretical Framework 
 The transtheoretical model (TTM) was used to predict and guide behavior changes 
among prescribing clinicians. This model elucidated how prescribing clinicians changed their 
behaviors at different stages of readiness to improve the quality of practice when treating uUTIs. 
People are at different stages of readiness when making health behavior changes, and analyses of 
the processes of change can help identify strategies for overcoming particular barriers to 
behavioral change (Glanz et al., 2015). If the perceived barriers are greater than the perceived 
benefits, the likelihood of behavior change decreases.  
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The TTM was augmented with the diffusion of innovations model, which focuses on the 
role of change agents in disseminating health interventions. Key constructs to behavior changes 
included the extent of effectiveness, cost (i.e., perceived cost, time, and effort), simplicity (i.e., 
ease of understanding), compatibility (i.e., fit with the intended audience), observability (i.e., 
observable outcomes), and trialability (i.e., the extent to which the innovation can be tried before 
commitment to change; Oldenburg & Glanz, 2008).  
 Strong motivation is also needed to yield behavior change in different settings and 
populations (Webb & Sheeran, 2006); the motivation to improve and evaluate current practice 
triggers behavioral changes. In the present project, the medical director and the director of allied 
education agreed (motivation) to set evidence-based clinical guidelines for quality practice 
improvement and outcomes (perceived benefit) and therefore approved the proposal. The clinic’s 
advanced practice nurse (APN) and the advanced practice nurse student (APNS; i.e., the change 
agents) were assigned responsibility for this project. After project approval, the change agents 
developed strategies to reduce restraining forces (barriers); these barriers included loss of patient 
time, use of break hours for training, and worries about the complexity of the change. Short, 
face-to-face change agents’ meetings were held during break times over food or snacks. The 
APNS was given safe and remote access to patients’ EHRs, from which the student collected 
data for review.  
Methods 
Context 
 Athena Health strives to provide the highest quality of care and customer service 
to residents and their families through best practices, highly trained staff, and 
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innovative programs and services designed to meet patients’ needs (Athena Healthcare 
Systems, 2020). As mentioned above, Athena Med-Monterey is a multi-practice clinic 
with multiple providers who are experts in their fields (these include obstetrics and 
gynecology, internal medicine, occupational medicine, and advanced practice nursing). 
Patients presenting with UTI symptoms are prescribed antibiotics, either at the initial 
visit or after two days, once urine culture and sensitivity results are available.  
Intervention  
 The PDSA method was used to guide the small test of change that aimed to 
measure practice outcomes and set the clinic’s evidenced-based uUTI treatment 
guidelines. This shorthand cycle was conducted in the initial phase of the three-year proposed 
intervention, from October 21, 2020, through January 4, 2021. A small test of change using the 
PDSA is an action-oriented method of testing a change by planning the change, trying it, 
observing the results, and acting on what is learned (Institute for Healthcare Improvement, 
2020).  Within the time allotted for the small test of change, the PDSA method was 
conducted in cycles as needed in the hope that the proposed changes led to the desired 
improvement. Project roles, communication delivery, and deliverables were clearly stated 
and followed.  
 The small test of change, which was guided by the plan-do-study-act (PDSA) method, 
was utilized because of its simplicity, fit, observability, and trialability. In the present project, the 
plan was to review practice, integrate the 2011 IDSA uUTI guidelines, and set the clinic’s 
treatment guidelines for treating uUTI. The change agents conducted (do) the qualitative 
assessment and the retrospective chart review. The current practices were also reviewed against 
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the 2011 IDSA treatment guidelines. Analyses (study) of the assessment results, as well as chart 
reviews and quality measurement, were used to determine an action. The change agents decided 
whether to adapt, adopt, or abandon (act) the plan for establishing clinical treatment guidelines 
for uUTI. The stages of behavior change were also observed and identified during this initial 
phase of the three-year proposal.  
Gap Analysis 
Although the patients’ treatment plans for uUTIs are clearly written in their EHRs, 
the clinic has no written clinical guidelines that reference evidence-based treatment 
guidelines such as the 2011 IDSA guidelines. Furthermore, the quality measurements for 
evaluating the treatment outcomes and clinical practices for treating uUTIs are currently 
not available (Table 2). Thus, inconsistencies could exist among the clinicians in the 
management and prescribing of antibiotics to treat uUTIs in PrMNPW. In addition, there are 
no supporting data available to indicate the clinic’s adherence to evidence -based clinical 
guidelines for the treatment of uUTIs, no supporting da ta to indicate the clinic’s 
adherence to prescribing first-line agents for uUTI, and no data available to quantify 
symptom resolution post treatments. Having written evidence-based treatment guidelines 
for uUTIs in PrMNPW could promote the adherence to these guidelines and support 
clinicians to consistently follow them and prescribe the defined first-line agents. Using 
real-time interoperable EHRs with electronic charting and prescription capabilities could 
likely influence this quality practice improvement. Further, continuous electronic 
monitoring could be performed using the clinic’s EHRs. The practice outcomes that the 
clinic could measure include adhering to the use of evidence-based practices and 
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prescribing first-line agents for the treatment of uUTI and not performing a urine culture 
when treating AUC. Furthermore, the additional treatment outcomes that the clinic could 
measure include symptom resolution at 28 days after the uUTI treatment. 
Gantt Chart 
After approval (Letter 1) was obtained from the clinic’s allied health education 
director in October 2020, two small tests of practice change or improvement were 
attempted during the initial phase of the three-year project timeline (Table 3). The APN 
and the APNS formed a team and were assigned as the change agents  to lead the small 
test of change. The qualitative assessment survey and retrospective review of the records 
were performed in October 2020. The records of women aged 18–50 with symptoms of 
uUTI (dysuria and frequency of urination) were collected for review. The clinicians’ 
references for treatment practices and adherence to prescribing first-line agents for 
treating uUTIs in PrMNPW were also reviewed in accordance with the 2011 IDSA 
evidence-based guidelines. During this initial phase, the attempt to establish clinic 
guidelines was abandoned, as the investigation found that the clinicians used resources 
that were based on the 2011 IDSA guidelines. Therefore, no practice changes  were 
proposed. Then, the aspects of the clinicians’ adherence to prescribing first-line agents 
for treating uUTIs in PrMNPW as well as symptom resolution within 28 days post  
treatment were measured. The first phase was completed on January 1, 2021. 
The subsequent chart review was completed, and the second attempt at proposing 
practice changes or improvements was identified on January 7, 2021. The second small 
test of change aimed to get clinicians to prescribe a first-line agent without performing a 
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urine culture for treating AUC. The 2011 IDSA and 2017 CDC guidelines do not 
recommend performing a urine culture for the treatment of AUC. This second small test 
of change was carried out from February 9, 2021 to February 20, 2021. A pre-
implementation clinician survey and a short face-to-face project review were conducted a 
week prior to commencing the second small test of change. 
This second attempt at practice improvement was not completed due to having 
limited access to EHRs. The planned intervention for this second attempt at practice 
improvement would have been as follows. Upon the acknowledgement of the uUTI 
symptoms being the patient’s chief complaint, the scheduling medical assistant would 
have added the following urine culture smart phrase to the problem alert box (Fig. 1): 
“Urine culture is not recommended for managing acute uncomplicated cystitis in non -
pregnant premenopausal women. However, for acute pyelonephritis and any type of 
complicated UTIs, a urine culture should be obtained before empiric therapy.  Consider 
pyelonephritis or complicated UTI in the presence of fever, flank pain, and/or nausea and 
vomiting.” 
Work Breakdown Structure 
The director of allied health education represents the clinic’s leadership and was 
informed and consulted throughout the project’s initial phase. The APN and the APNS 
are the change agents and were responsible for completing the project’s tasks. The tasks 
included performing a review of the clinic’s current uUTI practices in comparison with 
the 2011 IDSA guidelines, completing the qualitative assessment and retrospective chart 
review, analyzing and reporting the outcomes obtained, and presenting recommendations 
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to the director of allied health education.  The director of allied health education and the 
change agents interpreted the findings and outcomes and made the decision to abandon 
the proposed practice improvement. In addition, the clinicians were informed of the 
evaluation process and participated in the qualitative assessment (Table 4). 
Responsibility/Communication Matrix  
 The short face-to-face meetings between the change agent/s and the director of 
allied health education were held in an office during break times, over food, or after the 
last patients are seen on Wednesdays. The meeting agendas included discussing the plan 
and action items as well as the outcomes evaluation and analyses. The project updates 
and decisions produced during these meetings were recorded on paper by the APNS. The 
qualitative assessment and the remote electronic retrospective chart review were 
performed by the APNS, and the findings of these were reported by the APNS to the 
clinic leadership twice a month during the face-to-face meetings or through the 
University of San Francisco email system (Table 5). 
SWOT Analysis 
It is evident that the clinic has two strengths (S) with regard to quality practice and 
treatment outcomes. They are the real-time interoperable EHRs and the effective 
collaborations among clinicians. The electronic charting and prescription capabilities 
likely influenced the quality of the practices and treatment outcomes, with easily 
accessible electronic resource applications such as UpToDate, Medscape, Epocrates, and 
the CDC guidelines. Patients’ treatment plans are clearly written in their EHRs, and the 
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collaborations between clinicians are recorded through the clinic’s secure email and 
phone system for when questions regarding patient care arise. In addition, 75% of the 
clinicians are obstetricians and gynecologists. Their expert opinions are highly sought out 
in the clinic, the patient population of which is 90% women. The opportunities (O) for 
quality practice and treatment outcomes include establishing a culture that is supportive 
of practice changes and the existence of allied health education that accommodates 
students for health professional development. The weaknesses (W) include the 
unavailability of antibiograms, or records of local antibiotic resistance patterns, and the 
unavailability of continuous quality improvement tools. The constraints in the clinicians’ 
time and schedule could be considered threats (T) to quality practice and treatment 
outcomes (Figure 2). 
Budget 
 The first phase of the small tests of change did not have a negative financial impact. The 
estimated total budget for the three-year program was $8,015 (Table 6). An estimated $5,000 
was spent on data collection and analysis, and $3,000 was spent on meetings, trainings, and 
collaborations. About $15.00 was used to copy papers and purchase office supplies; however, the 
clinic had the office supplies and devices to meet these needs. Funds for this budget were taken 
from the clinic’s quality improvement and staff education and training funds.  
The clinicians’ offices were conducive for one-on-one in-service that maintained six feet 
of safe distance, given the COVID-19 pandemic precautions. The APNS was given remote EHR 
access and performed safe retrospective chart review of records. As previously mentioned, the 
clinic was equipped with interoperable EHR with real-time patient data and electronic charting 
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and prescription capabilities. The use of the clinic’s EHR incurred no additional expenses and 
most likely influenced this quality practice improvement.  
 The estimated return of investment for prescribing first-line agents when treating uUTIs 
was no recurrence or no return visit within 28 days post-treatment. The individual cost of UTI 
recurrence work-up ranges from $390–730 per individual (Gaitonde et. al, 2019). The clinic saw 
an average of eight cases of uUTI in two months; therefore, the savings were estimated to be 
$3,120–5,840 per patient with no recurrences at 28 days post-treatment. Additionally, not 
performing urine cultures for AUC eliminates additional documentation and follow-up calls for 
patient notification. If a clinician, with a salary of $100/hour, spent approximately 10 minutes 
calling and notifying a patient of a normal urine culture, the clinic could save approximately 
$800 per year by not performing urine cultures for AUC.  
Study of the Intervention 
 A retrospective chart review was performed to collect and use data to evaluate 
clinicians’ adherence to current evidence-based guidelines, such as the 2011 IDSA 
guidelines, when treating uUTI in PrMNPW. Additionally, structured qualitative surveys 
were conducted prior to each small test of change. The first survey (Deliverable 1) 
evaluated clinicians’ referencing of evidenced-based practice guidelines and their use of 
first-line agents for treating uUTI. The second survey (Deliverable 2) evaluated 
clinicians’ decisions to order urine cultures for AUC. Analyses of these data were used to 
guide proposed plans for practice improvements.  
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 Post-implementation surveys were intended to measure the practice improvement 
outcomes when an intervention occurred. However, analysis of both the initial qualitative 
survey and retrospective chart review found that clinicians adhered to the 2011 IDSA 
guidelines and prescribed first-line and alternative agents when treating uUTI in 
PrMNPW. Thus, the first planned intervention to establish clinic guidelines was 
abandoned. Furthermore, limited access to EHRs led to unmeasurable outcomes for the 
second planned intervention for practice improvement, which was a small test of change 
regarding not performing a urine culture when treating AUC.  
Outcome Measures 
 A completed cycle of the small test of change, guided by the PDSA method, is 
considered a successful practice and treatment outcome evaluation process. That is, a 
practice change was planned, tried on a small scale, studied, and an acted upon (whether 
to adopt, adapt, or abandon the planned practice change). Two primary outcome 
measurements were proposed to measure adherence to the guidelines. The first primary 
outcome involved the use of evidence-based clinical practice guidelines for treating uUTI 
in PrMNPW. The second primary outcome is adherence to prescribing the first-line 
agents NTF, SMX-TMP, or FM as opposed to prescribing FQ or β-lactams. Clinicians 
achieved adherence if a first-line antibiotic was not prescribed in the absence of 
contraindication showing that the patient did not meet the criteria for receiving first-line 
antibiotic treatment. The proposed secondary outcome measurement was symptom 
resolution. Absence of recurrences or return visits for the same uUTI symptoms within 28 
days post-treatment was considered symptom resolution. Furthermore, not performing a 
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urine culture when treating AUC was considered adherence to evidenced-based 
guidelines. However, as previously mentioned, limited EHR access did not allow for this 
small test of practice change.  
CQI Method  
 The PDSA method guided the small test of change (Fig. 3). The evaluation of clinicians’ 
adherence to evidence-based clinical practice guidelines for the treatment of uUTI in PrMNPW 
was successfully completed using the small test of change process in the first phase of the three-
year proposed intervention. Two qualitative pre-implementation surveys were conducted 
prior to each small test of change. The data from the retrospective patient chart review 
was used to quantify the total number of patients seen for uUTIs and to measure 
prescribing rate of first-line agents.  
Analysis 
 The rate of appropriately prescribing first-line agents for symptoms of uUTIs was 
used to determine prescription adherence. The rate was computed as the number of 
clinicians who adhered to prescribing first-line agents divided by the total number of 
patients seen for uUTIs. Summary statistics (frequencies and percentages) were used to 
quantify symptom reoccurrence. The retrospective review of data from October 25, 2021, 
through December 2, 2020, was used to measure these outcomes. A chi-square analysis 
would have been used to determine whether any significant increase in adherence to 
prescribing first-line agents to treat uUTIs in PrMNPW occurred after the proposed small 
test of change was implemented.  
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Initial reviews found that clinicians at Athena Med-Monterey used guidelines and 
resources referring to the 2011 IDSA guidelines. These resources guided them in 
prescribing first-line agents for treating uUTI. Therefore, no quality improvement 
intervention was needed; setting the clinic’s practice guidelines for treating uUTI would 
have been futile.  
 Two qualitative pre-implementation surveys were conducted prior to each small 
test of change. The first face-to-face semi-structured interview was conducted in the first 
phase on November 4, 2020, before the intended timeline for establishing clinical 
guidelines. This initial, qualitative pre-implementation survey identified two themes: 
resources clinicians referred to for antibiotic prescription decisions, and tailoring 
antibiotic treatments according to urine culture results in accordance with guidelines. The 
answers to the survey halted the small test of change and prompted the next phase of 
attempted practice change. The second face-to-face semi-structured interview was 
conducted on January 30, 2021, and was used to plan the second small test of practice 
change. The survey evaluated the clinicians’ practices  and perceptions of performing 
urine cultures for AUC.  
Ethical Considerations 
 This project was guided by the American Nurses Association (2015) Code of 
Ethics with Interpretive Statements. It was also guided by the Jesuit values (University of 
San Francisco, 2001) of protecting, promoting, and optimizing health and abilities, 
preventing illness, alleviating suffering through the human response to diagnosis and 
treatment, and advocating for the care of the individuals and populations served. By 
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promoting use of clinical practice guidelines based on evidence, the study aimed to guide 
clinicians to choose first-line agents for treating uUTI in women, thereby preventing 
unnecessary use of antibiotics in treating such infections. Decreasing the prevalence of 
antibiotic resistance applies the principle of nonmalefience  (i.e., do no harm), a nursing 
duty to protect patients’ safety. 
Every effort was made to protect the patients’ privacy and rights and to respect 
and promote each person’s dignity. The aggregation of data for this project did not 
contain any patient information and was stored on a locked computer with two-factor 
authentication. The data were destroyed four months after the project was completed. 
This project was approved by the University of San Francisco’s Doctor of Nursing 
Practice program as a quality improvement project not requiring review by the 
Institutional Review Board (Statement 1).  
Results 
 The evaluation of clinicians’ adherence to evidence-based clinical practice guidelines for 
the treatment of uUTI in PrMNPW was successfully completed using the small test of change 
process in the first phase of the three-year proposed intervention. The PDSA method guided the 
small test of change. The evaluation of clinicians’ adherence to prescribing first-line, or 
alternative agents, and symptom resolution at 28 days post-uUTI treatment were also 
successfully completed. This first phase was initiated on October 21, 2020 and was completed on 
January 1, 2021, with planned quality practice improvement aimed to establish evidenced-based 
clinical guidelines for treating uUTI in PrMNPW. The change agents performed the qualitative 
pre-intervention survey on November 4, 2020, and initiated the retrospective chart review on 
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October 28, 2020. Findings of both the qualitative interview and retrospective chart review were 
reviewed on December 5, 2020, and these findings guided the decision to abandon the first 
planned quality improvement intervention.  
The change agents then decided to continue the retrospective chart review until January 
1, 2021, to collect more data to measure the following: use of evidenced-base clinical guidelines 
or references, such as the 2011 IDSA guidelines; adherence to the evidence-based guidelines as 
measured by prescription of first-line agents for uUTI; and practice outcomes as measured by no 
symptom recurrence within 28 days post-treatment. 
 All eight prescribing clinicians participated in the structured pre-intervention survey. The 
face-to-face in-office interviews were scheduled in advanced and recorded on paper by the 
APNS. Out of eight of the prescribing clinicians at Athena Med-Monterey, 6 (75%) were 
obstetricians and gynecologists; one was a general medicine doctor, and one was an APN. The 
pre-intervention clinician survey identified guidelines that the clinicians referred to for treating 
uUTIs. All eight (100%) of the clinicians used the resource applications UpToDate, Medscape, 
and Athena Med’s Epocrates. The review found that these electronic resource applications refer 
to the 2011 IDSA guidelines for treating uUTI.  
The qualitative assessment questions revealed that all eight (100%) of the prescribing 
clinicians strongly agreed that other clinicians prescribing in their absence would prescribe first-
line agents for treating AUC in PrMNPW, in accordance with guidelines. Furthermore, all eight 
(100%) strongly agreed that clinicians prescribing in their absence would prescribe antibiotics 
according to urine culture results when treating uUTI, in accordance to guidelines, and all eight 
(100%) strongly agreed that clinicians prescribing in their absence would start, stop, or tailor 
antibiotic treatment according to urine culture results and guidelines for treating uUTI. The pre-
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intervention survey also found that all eight (100%) of the clinicians ordered urine cultures for 
AUC symptoms. 
 Data from September 25, 2020 to January 1, 2021 were collected for retrospective chart 
review. The data were used to measure the rate of adherence to prescribing first-line agents, 
measure the rate of adherence to not performing urine cultures for AUC, and quantify the 
number of patients who had uUTI symptom recurrence within 28 days post-treatment. A total of 
seven PrMNPW with documented symptoms of uUTI were seen. Their ages ranged from 18–47 
years old. Urine dipstick was performed for five (71%) of the seven patients, and urine cultures 
were performed for all (100%) seven patients. Of the patients who did not receive urine dipstick, 
two (29%) were seen via telehealth; therefore, urine dipstick could not be performed. All seven 
(100%) were treated for uUTIs in accordance with the 2011 IDSA guidelines. Four (57%) were 
appropriately prescribed first-line or alternative agents, and three (43%) were not prescribed 
antibiotic agents as indicated by urine culture results. No symptom recurrences were noted at 28 
days post antibiotic treatment. Furthermore, no cases of pyelonephritis were seen. 
Discussion 
Summary  
 The small test of practice change using the PDSA method demonstrated success in 
implementing a structured and inexpensive provider-driven process for evaluating adherence to 
evidence-based clinical practice guidelines at Athena Med-Monterey, a multi-provider primary 
care organization. Both qualitative assessment and retrospective chart review found that the 
clinicians at Athena Med-Monterey maintained consistent behaviors of using evidenced-based 
guidelines and adhered to prescribing first-line and alternative agents for treating uUTI in 
PrMNPW. No quality practice improvement intervention was needed, and the plan to establish 
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clinical treatment guidelines for uUTI was abandoned. The clinicians’ utilization of guidelines 
results in positive practice and treatment outcomes. The clinicians at Athena Med-Monterey are 
comfortable other clinicians, on his/her behalf, prescribe a first-line agent for the treatment of 
uUTI. The retrospective chart review also revealed that the clinicians’ adherence to prescribing 
first-line and alternative agents resulted in no symptom recurrence 28 days post-treatment.  
 The FNP led the quality improvement process using the small test of change and PDSA 
method, the TTM of behavior, and the clinic’s EHRs. This quality improvement intervention was 
carried out over a three-month period. The intention to improve the quality of practice was 
planned, trialed, evaluated, and acted upon. The TTM was used to predict and guide the 
clinicians’ expected behaviors to trial the quality improvement intervention. The qualitative 
assessment and retrospective chart review were used to measure practice behavior and outcomes. 
Interpretations 
 The findings aligned with the trials, systematic reviews, and meta-analyses conducted 
after the CDC’s 2017 review of the 2011 IDSA guidelines (Table 1). Clinicians who referenced 
evidence-based guidelines to manage uUTIs were most likely to prescribe first-line agents and 
yield desired patient outcomes in terms of bacterial and symptom resolution as well as cost-
effectiveness. The use of EHRs and resource applications, such as UpToDate, Medscape, and 
Athena Med’s Epocrates, influenced this quality practice at Athena Health. Real-time patient 
information and updated resource applications supported efficient and well-informed electronic 
prescription capabilities, and retrospective chart review (through EHRs) was also a cost-saving 
process for measuring quality practice outcomes. 
 The TTM’s stages of behavioral change occurred among the clinicians at Athena Med-
Monterey when evaluating the clinical practice and implementing processes to further improve 
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practice quality. Although no intervention was needed to change the current practice for treating 
uUTIs in PrMNPW, the motivation to improve and evaluate the current practice triggered 
behavioral changes. Four stages of behavior changes were observed during the initial phase of 
the three-year project proposal:  
1. Stage 1: The clinicians were aware of the need to evaluate the practice and practice 
outcomes but had no thought of adopting evaluation tools or processes. 
2. Stage 2: The clinicians acted on their decision to trial the small test of change and the 
PDSA processes for evaluating and improving the practice. 
3. Stage 3: The clinicians maintained their behavior of using current evidenced-based 
references when treating uUTIs in PrMNPW. 
4. Stage 4: The clinicians acted on a decision to abandon the planned practice improvement. 
They are yet to decide whether to adopt a further small test of change and PDSA 
processes to continue quality improvement. 
Both the qualitative assessment and the retrospective chart review found that clinicians at Athena 
Med-Monterey were consistent in using evidenced-based clinical guidelines and prescribing 
first-line agents for treating uUTI in PrMNPW. How and when this behavior change occurred 
was not assessed in this project.  
 Consistent utilization of evidence-based guidelines could advance adherence to 
prescribing first-line agents for treating uUTI in PrMNPW, specifically in a multi-provider 
primary healthcare organization. The small test of practice change using the PDSA method could 
be used to establish processes to evaluate and promote the use of evidence-based clinical 
guidelines and the use of first-line agents for treating other uncomplicated infections commonly 
seen in primary care, such as respiratory and skin infections. Clinicians at Athena Med-Monterey 
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will consider the possibility of adopting a small test of change and PDSA processes for other 
potential practice improvement in antibiotic prescribing.  
Limitations 
 Although uUTI are also common in women older than 50 years, this project only 
examined quality improvement for treating uUTIs in PrMNPW aged 18–50 years. Treatment 
guidelines for uUTIs in postmenopausal women were not included in the 2011 International 
Clinical Practice Guidelines for the Treatment of AUC and Pyelonephritis published by the 
IDSA and the European Society for Microbiology and Infectious Diseases.  
 Given the limitations surrounding healthcare during the COVID-19 pandemic, physical 
examinations and in-clinic urine dipstick tests were infeasible. Review of symptoms was 
performed through telehealth for two of the seven cases included in the retrospective chart 
review, and urine collection for culture was carried out in a laboratory (vs. clinic-performed 
urine dipstick). Also, local susceptibility information was unavailable, which limited the use of 
SMX-TMP as a first-line antibiotic choice for treating AUC.  
 As previously mentioned, both the qualitative assessment and the retrospective chart 
review found that clinicians at Athena Med-Monterey used evidenced-based clinical guidelines 
and first-line agents for treating uUTIs in PrMNPW. Since no practice change intervention 
occurred, pre- and post-intervention comparison was not conducted. Additionally, quality 
measurement tools were not available for comparing and quantifying the clinic’s practice 
outcomes. 
 The 2011 IDSA and 2017 CDC guidelines do not recommend performing urine cultures 
when treating AUC. Thus, not performing urine cultures is considered adherence to evidenced-
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based guidelines. This project attempted to measure this adherence, but limited access to EHRs 
did not allow for this small test of practice change. 
Conclusion 
 uUTIs are diagnosed and managed in primary healthcare. To control for antibiotic 
resistance and reduce antibiotic use, the small test of practice change using the PDSA method 
could be used to establish processes to evaluate and promote the use of evidence-based clinical 
guidelines in a multi-provider organization like Athena Med-Monterey. Consistent utilization of 
evidence-based guidelines advances adherence to prescribing first-line agents, improves the 
quality of clinical decisions, allows for the delivery of consistent care, and yields high-quality 
patient outcomes when treating uUTIs in PrMNPW. Therefore, this project recommends these 
APN-driven processes to promote the use of evidenced-based practice guidelines and first-line 
agents for the treatment of other uncomplicated infectious conditions seen in primary care, such 
as uUTIs in post-menopausal women and respiratory and skin infections. 
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Brief Description of Project:  
A) Aim:  
The overall goal of the proposed project is to promote adherence to evidence-based 
guidelines for treating uncomplicated urinary tract infections (uUTIs) for 
premenopausal non-pregnant women. 
B) Description of Intervention:  
The proposed project will use the 2011 IDSA clinical practice approach for treating 
uUTIs in pre-menopausal non-pregnant women, as well as the clinicians’ practice 
preferences, to set or modify practice guidelines. The plan-do-study-act method will be 
used to guide the small tests of practice change. 
C) How will this intervention change the practice?  
The proposal will examine whether integrating the 2011 IDSA approach into a primary 
clinic’s current uUTI management practices (vs. the clinic’s current practices alone) 
will increase adherence to evidence-based guidelines and evaluate opportunities to 
improve the quality of clinical decisions and patient outcomes over a few weeks’ series 
of small tests of change.  
C) Outcome measurements: 
The following measures could be used to evaluate the proposal’s outcomes: 
1. Clinicians who prescribed antibiotics in the four weeks after the implementation 
of the small tests of change referenced the clinical practice guidelines in the 
treatment of 80% of all the PrMNPW seen with UTI symptoms. 
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2. Out of all the PrMNPWs seen with UTI symptoms in the four weeks after the 
implementation of the small tests of change, 80% are prescribed the appropriate 
first-line agents for AUC. 
3. Out of all the PrMNPWs seen with UTI symptoms in the four weeks after the 
implementation of the small tests of change, 80% are prescribed the appropriate 
first-line agents for acute pyelonephritis.  
 
 This proposal will also attempt to quantify improvement in the quality of clinical 
decisions using clinical practice guidelines and measure symptom resolution at 28 days 
post uUTI treatment.  
 
 
To qualify as an evidence-based change in practice project, rather than a research project, the 
following criteria outlined in federal guidelines will be used 
(http://answers.hhs.gov/ohrp/categories/1569):  
☐   This project meets the guidelines for an evidence-based change in practice project as 
outlined in the project checklist (attached). Students may proceed with implementation. 
☐  This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence. 
Comments:   
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
Instructions: Answer YES or NO to each of the following statements: 
Project Title:  
 
YES NO 
The aim of the project is to improve the process or delivery of care with 
established/accepted standards or to implement evidence-based change. There is no 
intention of using the data for research purposes. 
   X  
The specific aim is to improve performance on a specific service or program and is 
a part of usual care. ALL participants will receive standard care. 
   X  
The project is NOT designed to follow a research design (e.g., hypothesis testing 
or group comparison, randomization, control groups, prospective comparison 
groups, cross-sectional, case control). The project does NOT follow a protocol that 
overrides clinical decision-making. 
   X  
The project involves the implementation of established and tested quality standards 
and/or systematic monitoring, assessment, or evaluation of the organization to 
ensure that existing quality standards are being met. The project will NOT develop 
paradigms, untested methods, or new untested standards. 
   X  
The project involves the implementation of care practices and interventions that are 
consensus-based or evidence-based. The project does NOT seek to test an 
intervention that is beyond current science and experience. 
   X  
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The project will be conducted by the staff where the project will take place and 
involves staff who are working at an agency that has an agreement with USF 
SONHP. 
   X  
The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
   X  
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of colleagues, 
students, and/or patients. 
   X  
If there is an intent to, or possibility of publishing your work, you and supervising 
faculty and the agency oversight committee are comfortable with the following 
statement in your methods section: “This project was undertaken as an evidence-
based change of practice project at X hospital or agency and as such was not 
formally supervised by the Institutional Review Board.”  
   X  
 
 
ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an 
evidence-based activity that does NOT meet the definition of research. IRB review is not 
required. Keep a copy of this checklist in your files. If the answer to ANY of these questions 
is NO, you must submit for IRB approval. 
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Study Design Sample Outcomes/Findings 
Qualitative analysis of 
PCPs’ prescribing decisions 
for urinary tract infections 
Grigoryan et al. (2019) 
Qualitative semi-
structured interviews and 
thematic analysis 
Eighteen PCPs practicing in two 
family medicine clinics in a large 
urban area in Texas between July 
2017 and November 2017 
Few providers relied on the IDSA 
guidelines for treating uUTIs. 
Antibiotic prescribing in 
New York State Medicare 
Part B beneficiaries 
diagnosed with cystitis 
between 2016 and 2017 
Yu et al. (2020) 
 
 
Retrospective cohort study 
of Medicare Part B 
enrollees in New York 
State 
There were 23,981 and 26,677 
prescriptions written for cystitis 
across New York State in 2016 and 
2017, respectively. 
 
SMX-TMP, fosfomycin, and B-
lactamase prescriptions increased, and 
FQ use decreased in older female and 
male adults. 
The results suggested that the 
widespread prevalence of FQ and B-
lactamase prescriptions necessitates 
outpatient antimicrobial stewardship. 
Preferential use of NTF 
over FQ for AUC and 
outpatient E. coli resistance 
in an integrated healthcare 
system 





An urban setting in Colorado, a 477-
bed hospital, an emergency 
department, an urgent care 
department, eight community health 
clinics, and 15 school-based clinics 
This study included 5,714 adults 
treated for acute cystitis and 11,367 
outpatient E. coli isolates. 
After a change in institutional 
guidelines, there was an immediate 26% 
reduction in FQ use and stabilization of 
FQ-resistant E. coli. NTF use increased 
without any change in NTF resistance.  
 
Evaluation of the trends and 
appropriateness of FQ use 
in the outpatient treatment 
of AUC at five family 
practice clinics 
Robinson et al. (2019) 
 
Retrospective study Women aged 19–64 years old were 
seen at five family medicine clinics 
and prescribed NTF, ciprofloxacin, 
or levofloxacin for uncomplicated 
cystitis. 
Of the 567 women included in this 
study, 395 were given NTF, and 172 
were given FQ; 343 (86.8%) and 18 
(10.5%) were appropriately prescribed 
NTF and FQ, respectively. Of the 
women who were inappropriately 
prescribed FQ, 15 (87.8%) lacked 
contraindication to NTF. 
Improvement in adherence 
to antibiotic duration of 
therapy recommendations 
for uncomplicated cystitis: 
A quasi-experimental study 
Giancola et al. (2019) 
Quasi-experimental study Women aged 18–64 years old who 
were prescribed NTF, SMX-TMP, 
or ciprofloxacin within seven days 
of encounters at five family 
medicine clinics 
Clinics that received education 
increased adherence from 22.1% to 
58.8% (p < 0.01). Revising/adding 
default prescription instructions to 
targeted antimicrobials and DOT, and 
staff in-service increased clinician 
adherence to uncomplicated cystitis 
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(n = 31) 
Records after duplicates removed 
n56- 19duplicates = 37 
(n = 37) 
Records screened 
n=37 
(n =   ) 
Records excluded 
(n =18) 
2 recurrent cystitis 
1 green tea treatment 
1 kidney transplant 
3 pregnant women 
1 cefditoren pivoxil 
1 uroprofit, chronic cystitis 
1 phytotherapeutic med 
1 overactivity/incontinence 
1 mecillinenam 
1 complicated cystitis (DM) 
1 article not available 
4 no full text available 
 





Full-text articles excluded,  
with reasons 
(n = 8) 
1 Not specific to prescribing first-line 
antibiotics. 
1 Cepodoxime study 
1 recurrent infection and MDR 
1 Urine culture cost effectiveness 
1 Generic vs brand name antibiotics 
1 pharmacokinetics of 
nitrofurantoin 
1 Guideline review 














Focus Area Current 
Situation 
Desired Situation Gap Factor/ 
Deficiency 
Action Plan 
Use of clinical practice 
guidelines, such as the 
2011 IDSA, in the 
treatment of uUTIs.  
No available data 
 
 
Use of the 2011 IDSA 
approach to uUTI 
treatment is evident 
and available for 
reference. 
 
A diagram of the 2011 
IDSA approach to 
uUTI treatment is 








Perform clinician survey. 
 
The 2011 IDSA approach to 
AUC treatment is available for 
reference. This may be 
modified according to survey 
results and according to the 
PDSA method to reflect what 




symptoms of AUC are 
prescribed appropriate 
first-line agents in 
accordance with the 
2011 IDSA guidelines. 
No data PrMNPWs with 
symptoms of AUC 
will be prescribed 
appropriate first-line 
agents in accordance 
with the 2011 IDSA 
guidelines. 
No available data Recommend use of clinical 
practice guidelines and quality 
measurement tools and/or 
evaluation process. 
PrMNPWs with 
symptoms of acute 
pyelonephritis will have 
their urine sent for 
culture in accordance 
with the 2011 IDSA 
guidelines.  
No data Clinicians wait for 
urine culture results 
and prescribe first-line 
agents in accordance 
with the 2011 IDSA 
guidelines.  
No available data Recommend use of clinical 
practice guidelines and quality 
measures. 
 
Patients with uncertain 
diagnoses will have 
their urine sent for 
culture to confirm 
antibiotic treatment. 
No data Patients with uncertain 
diagnoses will have 
their urine sent for 
culture to confirm 
antibiotic treatment. 
No available data Continue practice. 
PrMNPW treated for 
symptoms of uUTI 
report symptom relief 
within 48 hours after 
being seen at the clinic, 
and symptom resolution 
at 28-days post uUTI 
treatment. 
No data Patients report 
symptom relief within 
48 hours after being 
seen at the clinic or 
symptom resolution at 
28-days post-uUTI 
treatment. 
No available data Recommend use of quality 









Timeline (Gantt Chart) 
Year 1 Tasks  Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug 
Formation of one clinician team for a 
small test of change using the PDSA 
method 
 
            
Four-week retrospective chart review of 
the target population treated for UTI 
symptoms 
 
Integration of the 2011 IDSA Approach 
to uUTI Treatment into the clinic’s 
current practices 
 
            
Initial small test of change begins 
 
Use of the PDSA method 
 
            
Initial small test of change evaluation 
Plan second small test of change 
 
Outcome measurement and report 
 
           
Full implementation 
 
            
First-year post-implementation survey 
 
            
Report distribution 
 
            
 
Year 2 Tasks  Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep 
Full implementation of the PDSA 
method 
 
            
Outcome measurement and report 
 




Outcome measurement and report 
 
            
Report distribution 
 







Year 3 Tasks  Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep 
Full implementation of the PDSA 
method 
 
            
Outcome measurement and report 
 
            
Third-year post-implementation survey 
 
Outcome measurement and report 
 
            
Report distribution 
 





















Figure 1  
















Table 4  
Small Test of Change Work Breakdown Structure 
Project clinic leadership: Allied Health Education Director 
 
Change agents: APN and APNS 
 
Participants: All of the clinic’s prescribing clinicians 
 
 
Responsible (R): Member is responsible for completing the task 
Consulted (C): Member was communicated with regarding the decision and task  
Informed (I): Member was updated on decisions and actions  
 
 













      
       APN and FNP student 
 
Initialization Phase   
Review the 2011 IIDSA Approach to uUTI Treatment vs Athena 
Med-Monterey clinicians’ resource/guidelines 
 
               I/C                  R 
Planning Phase   
Perform a four-week retrospective chart review of the target 
population treated for UTI symptoms. 
 
Print and laminate the modified approach diagram and place it in 
a visible position for reference. 
 
Staff in-service sessions given prior to implementation. 
 
               I/C                  R 
Implementation Phase of the Small Test of Change   
Prescribers refer to guidelines. 
Conduct the PDSA method in cycles as needed for the desired 
quality practice.  
 
                 I                  R 
Evaluation and Assessment Phase    
Analyze and report outcomes to the medical director. 
 
                 I                  R 
Review Phase   
Create lessons learned. 
 
                 I                  R 
Make the decision to continue or terminate the initiative. 
 
                 R                  I 
Create a project closure report and present recommendations.  
 














Once Present project 
























Once at first 
phase of 
implementation, 
and initiation of 
small test of 
change 
Present study 





















Weekly Review project 
status using the 
PDSA method 
and plan next 
steps for small 




















































next small test 





















Figure 2  






Clinic has a fast and reliable EHR system.
Clinic performed dipstick and urine culture and sensitivity tests 
and received results within 48-72 hours through the EHRs
Accessible resource applications (UpToDate, Medscape, 
Epocrates) in EHR
Efficient collaborations among clinicians through clinic e-
mails and phone system
Weaknesses
Multi-provider organization
Antibiogram is currently unavailable to 
support clinical decision-making.
Measurement tools are currently 
unavailable to quantify quality care.
Opportunities
Use of quality measures to evaluate practice and 
treatment outcomes
Culture is supportive of practice change for 
improvement
Threats






Estimated Three-Year Budget 
 
 Breakdown Revenue Expenses Expenses Expenses 













Materials 4 copies of the 
clinical guidelines 
 
4 laminated sheets of 





$15 $0 $0 
Training cost for each 
of the eight clinicians  
 
15 minutes in-service 















8 hours collaboration 
with Medical 






(Indirect care from 
education and 
training fund) 
$800 $0 $0 
Data collection and 




80 hours or 10 days 










$2000 $0 $0 
Quality measures 





40 hours or 5 days 
(3 months and yearly 
post implementation) 
 








staff training fund 





3-year revenue for 
























1. I use the ________ clinical practice guidelines in the treatment of uncomplicated urinary tract 
infections. 
 
 2008 ACOG (The American College of Obstetricians and Gynecologists) 
 2017 CDC (Centers for Disease Control and Prevention) 
 2011 IDSA (Infectious Disease Society of America) 
 Athena Clinical Guidelines 
 App-based Resources: 
  UpToDate 
  Epocrates 
  Medscape 
 Other(s): ___________________________ 
 
2. I feel comfortable that the clinicians prescribing in my absence: 
a. Choose first-line agents in the treatment of uncomplicated cystitis according to the 
guidelines I use. 




 Strongly disagree 
 
b. Choose appropriate antibiotics for treating uncomplicated pyelonephritis once urine 
culture and sensitivity results are known and in accordance with the guidelines I use. 




 Strongly disagree 
 
c. Start, stop, or tailor antibiotic treatment according to urine culture results and according 
to guidelines I use for treating uncomplicated urinary tract infections.  













1. I know the differences in symptoms between AUC and pyelonephritis according to the 
2011 IDSA and the 2017 CDC guidelines.  
 
  Strongly agree        
  Agree             
  Somewhat agree 
  Disagree          
  Strongly disagree 
 
 
2. I order urine cultures to treat AUC at the day of clinic visit, before the first dose of 
antibiotics. 
 
  All the time          
  Often           
  Half the time          
  At times          
  Never 
 
 
3. I feel confident in prescribing first-line agents for treating AUC without performing urine 
cultures. 
 
  Strongly agree       
  Agree             
  Somewhat agree 
  Disagree          























   
           
                  
 
Act:




based clinical practice 








Implement small test 





What are we trying to accomplish? 
Promote adherence to evidenced-based 
clinical practice guidelines 
How will we know that a change is an 
improvement? 
Evaluate current practice and outcomes 
(qualitative and retrospective) 
 
What changes can we make that will 
result in improvement? 
Implement small test of practice change 
